This is a preview of subscription content, log in via an institution to check access.
References
Fluehler H, Grieve AP, Mandallaz D, Mau J, Moser HA (1983) Bayesian approach to bioequivalence assessment: an example. J Pharm Sci 72: 1178–1191
Grieve AP (1985) A Bayesian analysis of the two-period crossover design for clinical trials. Biometrics 41: 979–990
Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 21: 467–480
Mandallaz D, Mau J (1981) Comparison of different methods for decision-making in bioequivalence assessmen. Biometrics 37: 213–222
Pabst G, Jaeger H (1990) Review of methods and criteria for the evaluation of bioequivalence studies. Eur J Clin Pharmacol 38: 5–10
Racine A, Grieve AP, Flühler H, Smith AFM (1986) Bayesian methods in practice; experiences in the pharmaceutical industry. Appl Statist 35: 93–150
Racine-Poon A, Grieve AP (1985) A Non-parametric confidence interval method. Eur J Clin Pharmacol 29: 379–381
Racine-Poon A, Grieve AP, Flühler H, Smith AFM (1986) A two-stage procedure for bioequivalence studies. Biometrics 43: 847–856
Schuirmann DJ (1987) A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokin Biopharm 15: 657–680
Selwyn MR, Dempster AP, Hall NR (1981) A Bayesian approach to bioequivalence for the 2 × 2 changeover design. Biometrics 37: 11–21
Selwyn MR, Hall NR (1984) On Bayesian methods for bioequivalence. Biometrics 40: 1103–1108
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grieve, A.P., Pabst, G. Evaluation of bioequivalence studies. Eur J Clin Pharmacol 40, 201–202 (1991). https://doi.org/10.1007/BF00280080
Issue Date:
DOI: https://doi.org/10.1007/BF00280080